Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements (original) (raw)

References

• AVILA, J., DOMINGUEZ, J. & DIAZ-NIDO, J. (1994) Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. International Journal of Developmental Biology 38, 13–25.
  CAS PubMed Google Scholar
• AYLWARD, E. H., ANDERSON, N. B., BYLSMA, F. W., WAGSTER, M. V., BARTA, P. E., SHERR, M., FEENEY, J., DAVIS, A., ROSENBLATT, A., PEARLSON, G. D. & ROSS, C. A. (1998) Frontal lobe volume in patients with Huntington’s disease. Neurology 50, 252–258.
  CAS PubMed Google Scholar
• BEAL, M. F., KOWALL, N. W., ELLISON, D. W., MAZUREK, M. F., SWARTZ, K. J. & MARTIN, J. B. (1986) Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid. Nature 321, 168–171.
  CAS PubMed Google Scholar
• BERRIOS, G. E., WAGLE, A. C., MARKOVA, I. S., WAGLE, S. A., HO, L. W., RUBINSZTEIN, D. C., WHITTAKER, J., FFRENCH-CONSTANT, C., KERSHAW, A., ROSSER, A., BAK, T. & HODGES, J. R. (2001) Psychiatric symptoms and CAG repeats in neurologically asmptomatic Huntington’s disease carriers. Psychiatry Research 102, 217–225.
  CAS PubMed Google Scholar
• BLOCK-GALARZA, J., CHASE, K. O., SAPP, E., VAUGHN, K. T., VALLEE, R. B., DIFIGLIA, M. & ARONIN, N. (1997) Fast transport and retrograde movement of huntingtin and HAP 1 in axons. NeuroReport 8, 2247–2251.
  CAS PubMed Google Scholar
• BORDELON, Y. M. & CHESSELET, M. F. (1999) Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia. Neuroscience 93, 843–853.
  CAS PubMed Google Scholar
• BRUGG, B. & MATUS, A. (1991) Phosphorylation determines the binding of microtubule-associated protein 2 (MAP2) to microtubules in living cells. Journal of Cell Biology 114, 735–743.
  CAS PubMed Google Scholar
• CEPEDA, C., HURST, R. S., CALVERT, C. R., HERNANDEZ-ECHEAGARAY, E., NGUYEN, O. K., JOCOY, E., CHRISTIAN, L. J., ARIANO, M. A. & LEVINE, M. S. (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington’s disease. Journal of Neuroscience 23, 961–969.
  CAS PubMed Google Scholar
• CHA, J. H. (2000) Transcriptional dysregulation in Huntington’s disease. Trends in Neuroscience 23, 387–392.
  CAS Google Scholar
• CUDKOWICZ, M. & KOWALL, N. W. (1990) Degeneration of pyramidal projection neurons in Huntington’s disease cortex. Annals of Neurology 27, 200–204.
  CAS PubMed Google Scholar
• DE LA MONTE, S. M., VONSATTEL, J. P. & RICHARDSON, E. P., JR. (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington’s disease. Journal of Neuropathology & Experimental Neurology 47, 516–525.
  Google Scholar
• DESAI, A. & MITCHISON, T. J. (1997) Microtubule polymerization dynamics. Annual Review of Cell & Developmental Biology 13, 83–117.
  Google Scholar
• DEWHURST, K. (1969) Neuro-psychiatric aspects of Huntington’s disease. Confinia Neurologica 31, 258–268.
  CAS PubMed Google Scholar
• DIAZ-NIDO, J., MONTORO, R. J., LOPEZ-BARNEO, J. & AVILA, J. (1993) High external potassium induces an increase in the phosphorylation of the cytoskeletal protein MAP2 in rat hippocampal slices. European Journal of Neuroscience 5, 818–824.
  CAS PubMed Google Scholar
• DIFIGLIA, M., SAPP, E., CHASE, K., SCHWARZ, C., MELONI, A., YOUNG, C., MARTIN, E., VONSATTEL, J. P., CARRAWAY, R., & REEVES, S. A. (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075–1081.
  CAS PubMed Google Scholar
• DIFIGLIA, M., SAPP, E., CHASE, K. O., DAVIES, S. W., BATES, G. P., VONSATTEL, J. P. & ARONIN, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993.
  CAS PubMed Google Scholar
• DOM, R., MALFROID, M. & BARO, F. (1976) Neuropathology of Huntington’s chorea. Studies of the ventrobasal complex of the thalamus. Neurology 26, 64–68.
  CAS Google Scholar
• ELDER, G. A., FRIEDRICH, V. L., JR., BOSCO, P., KANG, C., GOUROV, A., TU, P. H., LEE, V. M. & LAZZARINI, R. A. (1998a) Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content. Journal of Cell Biology 141, 727–739.
  CAS Google Scholar
• ELDER, G. A., FRIEDRICH, V. L., JR., KANG, C., BOSCO, P., GOUROV, A., TU, P. H., ZHANG, B., LEE, V. M. & LAZZARINI, R. A. (1998b) Requirement of heavy neurofilament subunit in the development of axons with large calibers. Journal of Cell Biology 143, 195–205.
  CAS Google Scholar
• ENGQVIST-GOLDSTEIN, A. E., WARREN, R. A., KESSELS, M. M., KEEN, J. H., HEUSER, J. & DRUBIN, D. G. (2001) The actin-binding protein Hip1R associates with clathrin during early stages of endocytosis and promotes clathrin assembly in vitro. Journal of Cell Biology 154, 1209–1223.
  CAS PubMed Google Scholar
• FOLSTEIN, S. E. (1983) Psychiatric features of Huntington’s disease: Recent approaches and findings. Psychiatric Developments 1, 193–205.
  CAS PubMed Google Scholar
• FOROUD, T., SIEMERS, E., KLEINDORFER, D., BILL, D. J., HODES, M. E., NORTON, J. A., CONNEALLY, P. M. & CHRISTIAN, J. C. (1995) Cognitive scores in carriers of Huntington’s disease gene compared to noncarriers. Annals of Neurology 37, 657–664.
  CAS PubMed Google Scholar
• GUIDETTI, P., CHARLES, V., CHEN, E.-Y., REDDY, P. H., KORDOWER, J. H., WHETSELL, W. O., JR., SCHWARCZ, R. & TAGLE, D. A. (2001) Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Experimental Neurology 169, 340–350.
  CAS PubMed Google Scholar
• GUNAWARDENA, S., HER, L. S., BRUSCH, R. G., LAYMON, R. A., NIESMAN, I. R., GORDESKY-GOLD, B., SINTASATH, L., BONINI, N. M. & GOLDSTEIN, L. S. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.[see comment]. Neuron 40, 25–40.
  CAS PubMed Google Scholar
• GUTEKUNST, C. A., LEVEY, A. I., HEILMAN, C. J., WHALEY, W. L., YI, H., NASH, N. R., REES, H. D., MADDEN, J. J. & HERSCH, S. M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proceedings of the National Academy of Sciences of the United States of America 92, 8710–8714.
  CAS Google Scholar
• HALPAIN, S. & GREENGARD, P. (1990) Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron 5, 237–246.
  CAS PubMed Google Scholar
• HARJES, P. & WANKER, E. E. (2003) The hunt for huntingtin function: Interaction partners tell many different stories. Trends in Biochemical Science 28, 425–433.
  CAS Google Scholar
• HARMS, L., MEIERKORD, H., TIMM, G., PFEIFFER, L. & LUDOLPH, A. C. (1997) Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington’s disease: A proton magnetic resonance spectroscopy study. Journal of Neurology, Neurosurgery & Psychiatry 62, 27–30.
  Google Scholar
• HARPER, P. S. (1992) The epidemiology of Huntington’s disease. Human Genetics 89, 365–376.
  CAS PubMed Google Scholar
• HARRISON, P. J. & EASTWOOD, S. L. (1998) Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352, 1669–1673.
  CAS PubMed Google Scholar
• HENZE, D. A., CAMERON, W. E. & BARRIONUEVO, G. (1996) Dendritic morphology and its effects on the amplitude and rise-time of synaptic signals in hippocampal CA3 pyramidal cells. Journal of Comparative Neurology 369, 331–344.
  CAS PubMed Google Scholar
• HICKS, R. R., SMITH, D. H. & MCINTOSH, T. K. (1995) Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Research 678, 151–160.
  CAS PubMed Google Scholar
• HUNTINGTON’S DISEASE COLLABORATIVE RESEARCH GROUP (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72, 971–983.
  Google Scholar
• JACKSON, M., GENTLEMAN, S., LENNOX, G., WARD, L., GRAY, T., RANDALL, K., MORRELL, K. & LOWE, J. (1995) The cortical neuritic pathology of Huntington’s disease. Neuropathology & Applied Neurobiology 21, 18–26.
  Google Scholar
• JASON, G. W., SUCHOWERSKY, O., PAJURKOVA, E. M., GRAHAM, L., KLIMEK, M. L., GARBER, A. T. & POIRIER-HEINE, D. (1997) Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Archives of Neurology 54, 1081–1088.
  CAS PubMed Google Scholar
• JIAO, Y., SUN, Z., LEE, T., FUSCO, F. R., KIMBLE, T. D., MEADE, C. A., CUTHBERTSON, S. & REINER, A. (1999) A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. Journal of Neuroscience Methods 93, 149–162.
  CAS PubMed Google Scholar
• JOHNSON, G. V. & JOPE, R. S. (1992) The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. Journal of Neuroscience Research 33, 505–512.
  CAS PubMed Google Scholar
• KAECH, S., LUDIN, B. & MATUS, A. (1996) Cytoskeletal plasticity in cells expressing neuronal microtubule-associated proteins. Neuron 17, 1189–1199.
  CAS PubMed Google Scholar
• LAFORET, G. A., SAPP, E., CHASE, K., MCINTYRE, C., BOYCE, F. M., CAMPBELL, M., CADIGAN, B. A., WARZECKI, L., TAGLE, D., REDDY, P. H., CEPEDA, C., CALVERT, C. R., JOKEL, E. S., KLAPSTEIN, G. J., ARIANO, M. A., LEVINE, M. S., DIFIGLIA, M. & ARONIN, N. (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington’s disease. Journal of Neuroscience 21, 9112–9123.
  CAS PubMed Google Scholar
• LAWRENCE, A. D., HODGES, J. R., ROSSER, A. E., KERSHAW, A., FFRENCH-CONSTANT, C., RUBINSZTEIN, D. C., ROBBINS, T. W. & SAHAKIAN, B. J. (1998) Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain 121, 1329–1341.
  Article PubMed Google Scholar
• LAWRENCE, A. D., SAHAKIAN, B. J., HODGES, J. R., ROSSER, A. E., LANGE, K. W. & ROBBINS, T. W. (1996) Executive and mnemonic functions in early Huntington’s disease. Brain 119, 1633–1645.
  PubMed Google Scholar
• LEE, W. C., YOSHIHARA, M. & LITTLETON, J. T. (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington’s disease. Proceedings of the National Academy of Sciences of the United States of America 101, 3224–3229.
  Article CAS PubMed Google Scholar
• LI, H., LI, S. H., JOHNSTON, H., SHELBOURNE, P. F. & LI, X. J. (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity [see comments]. Nature Genetics 25, 385–389.
  Article CAS PubMed Google Scholar
• LI, H., LI, S. H., YU, Z. X., SHELBOURNE, P. & LI, X. J. (2001) Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington’s disease mice. Journal of Neuroscience 21, 8473–8481.
  CAS PubMed Google Scholar
• LI, M., SOBUE, G., DOYU, M., MUKAI, E., HASHIZUME, Y. & MITSUMA, T. (1995a) Primary sensory neurons in X-linked recessive bulbospinal neuropathy: Histopathology and androgen receptor gene expression. Muscle & Nerve 18, 301–308.
  Google Scholar
• LI, X. J., LI, S. H., SHARP, A. H., NUCIFORA, F. C., JR., SCHILLING, G., LANAHAN, A., WORLEY, P., SNYDER, S. H. & ROSS, C. A. (1995b) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398–402.
  Article CAS Google Scholar
• LUTHI-CARTER, R., STRAND, A., PETERS, N. L., SOLANO, S. M., HOLLINGSWORTH, Z. R., MENON, A. S., FREY, A. S., SPEKTOR, B. S., PENNEY, E. B., SCHILLING, G., ROSS, C. A., BORCHELT, D. R., TAPSCOTT, S. J., YOUNG, A. B., CHA, J. H. & OLSON, J. M. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease. Human Molecular Genetics 9, 1259–1271.
  Article CAS PubMed Google Scholar
• MANN, D. M., OLIVER, R. & SNOWDEN, J. S. (1993) The topographic distribution of brain atrophy in Huntington’s disease and progressive supranuclear palsy. Acta Neuropathologica 85, 553–559.
  CAS PubMed Google Scholar
• MATUS, A., BERNHARDT, R., BODMER, R. & ALAIMO, D. (1986) Microtubule-associated protein 2 and tubulin are differently distributed in the dendrites of developing neurons. Neuroscience 17, 371–389.
  Article CAS PubMed Google Scholar
• MCMURRAY, C. T. (2000) Neurodegeneration: Diseases of the cytoskeleton? Cell Death & Differentiation 7, 861–865.
  Google Scholar
• METZLER, M., LEGENDRE-GUILLEMIN, V., GAN, L., CHOPRA, V., KWOK, A., MCPHERSON, P. S. & HAYDEN, M. R. (2001) HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. Journal of Biological Chemistry 276, 39271–39276.
  Article CAS PubMed Google Scholar
• MODREGGER, J., DIPROSPERO, N. A., CHARLES, V., TAGLE, D. A. & PLOMANN, M. (2002) PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington’s disease brains. Human Molecular Genetics 11, 2547–2558.
  Article CAS PubMed Google Scholar
• MORTON, A. J. & EDWARDSON, J. M. (2001) Progressive depletion of complexin II in a transgenic mouse model of Huntington’s disease. Journal of Neurochemistry 76, 166–172.
  Article CAS PubMed Google Scholar
• MORTON, A. J., FAULL, R. L. & EDWARDSON, J. M. (2001) Abnormalities in the synaptic vesicle fusion machinery in Huntington’s disease. Brain Research Bulletin 56, 111–117.
  Article CAS PubMed Google Scholar
• MURPHY, K. P., CARTER, R. J., LIONE, L. A., MANGIARINI, L., MAHAL, A., BATES, G. P., DUNNETT, S. B. & MORTON, A. J. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington’s disease mutation. Journal of Neuroscience 20, 5115–5123.
  CAS PubMed Google Scholar
• NAGAI, Y., ONODERA, O., CHUN, J., STRITTMATTER, W. J. & BURKE, J. R. (1999) Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network. Experimental Neurology 155, 195–203.
  Article CAS PubMed Google Scholar
• NICNIOCAILL, B., HARALDSSON, B., HANSSON, O., O’CONNOR, W. T. & BRUNDIN, P. (2001) Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. European Journal of Neuroscience 13, 206–210.
  Article CAS PubMed Google Scholar
• ONO, S., BAUX, G., SEKIGUCHI, M., FOSSIER, P., MOREL, N. F., NIHONMATSU, I., HIRATA, K., AWAJI, T., TAKAHASHI, S. & TAKAHASHI, M. (1998) Regulatory roles of complexins in neurotransmitter release from mature presynaptic nerve terminals. European Journal of Neuroscience 10, 2143–2152.
  Article CAS PubMed Google Scholar
• PAULSON, H. L. & FISCHBECK, K. H. (1996) Trinucleotide repeats in neurogenetic disorders. Annual Review of Neuroscience 19, 79–107.
  Article CAS PubMed Google Scholar
• PLOMANN, M., LANGE, R., VOPPER, G., CREMER, H., HEINLEIN, U. A., SCHEFF, S., BALDWIN, S. A., LEITGES, M., CRAMER, M., PAULSSON, M. & BARTHELS, D. (1998) PACSIN, a brain protein that is upregulated upon differentiation into neuronal cells. European Journal of Biochemistry 256, 201–211.
  Article CAS PubMed Google Scholar
• SAPP, E., PENNEY, J., YOUNG, A., ARONIN, N., VONSATTEL, J. P. & DIFIGLIA, M. (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. Journal of Neuropathology and Experimental Neurology 58, 165–173.
  CAS PubMed Google Scholar
• SAPP, E., SCHWARZ, C., CHASE, K., BHIDE, P. G., YOUNG, A. B., PENNEY, J., VONSATTEL, J. P., ARONIN, N. & DIFIGLIA, M. (1997) Huntingtin localization in brains of normal and Huntington’s disease patients. Annals of Neurology 42, 604–612.
  Article CAS PubMed Google Scholar
• SCHNELL, S. A., STAINES, W. A. & WESSENDORF, M. W. (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. Journal of Histochemistry & Cytochemistry 47, 719–730.
  Google Scholar
• SHARP, A. H., LOEV, S. J., SCHILLING, G., LI, S. H., LI, X. J., BAO, J., WAGSTER, M. V., KOTZUK, J. A., STEINER, J. P., LO, A., ET AL. (1995) Widespread expression of Huntington’s disease gene (IT15) protein product. Neuron 14, 1065–1074.
  Article CAS PubMed Google Scholar
• SOLLNER, T. H. (2003) Regulated exocytosis and SNARE function (Review) Molecular Membrane Biology 20, 209–220.
  Article PubMed Google Scholar
• SOLLNER, T., WHITEHEART, S. W., BRUNNER, M., ERDJUMENT-BROMAGE, H., GEROMANOS, S., TEMPST, P. & ROTHMAN, J. E. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature 362, 318–324.
  Article CAS PubMed Google Scholar
• SOTREL, A., PASKEVICH, P. A., KIELY, D. K., BIRD, E. D., WILLIAMS, R. S. & MYERS, R. H. (1991) Morphometric analysis of the prefrontal cortex in Huntington’s disease. Neurology 41, 1117–1123.
  CAS PubMed Google Scholar
• SOTREL, A., WILLIAMS, R. S., KAUFMANN, W. E. & MYERS, R. H. (1993) Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington’s disease: A quantitative Golgi study. Neurology 43, 2088–2096.
  CAS PubMed Google Scholar
• STRONG, T. V., TAGLE, D. A., VALDES, J. M., ELMER, L. W., BOEHM, K., SWAROOP, M., KAATZ, K. W., COLLINS, F. S. & ALBIN, R. L. (1993) Widespread expression of the human and rat Huntington’s disease gene in brain and nonneural tissues. Nature Genetics 5, 259–265.
  Article CAS PubMed Google Scholar
• SUHR, S. T., SENUT, M. C., WHITELEGGE, J. P., FAULL, K. F., CUIZON, D. B. & GAGE, F. H. (2001) Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. Journal of Cell Biology 153, 283–294.
  Article CAS PubMed Google Scholar
• SZEBENYI, G., MORFINI, G. A., BABCOCK, A., GOULD, M., YOUNG, M., FABER, P. W., MACDONALD, M. E., MCPHAUL, M. J. & BRADY, S. T. (2003) Neuropathic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40, 41–52.
  Article CAS PubMed Google Scholar
• TAKAHASHI, S., UJIHARA, H., HUANG, G. Z., YAGYU, K. I., SANBO, M., KABA, H. & YAGI, T. (1999) Reduced hippocampal LTP in mice lacking a presynaptic protein: Complexin II. European Journal of Neuroscience 11, 2359–2366.
  Article CAS PubMed Google Scholar
• TROTTIER, Y., DEVYS, D., IMBERT, G., SAUDOU, F., AN, I., LUTZ, Y., WEBER, C., AGID, Y., HIRSCH, E. C. & MANDEL, J. L. (1995) Cellular localization of the Huntington’s disease protein and discrimination of the normal and mutated form [see comments]. Nature Genetics 10, 104–110.
  Article CAS PubMed Google Scholar
• TUKAMOTO, T., NUKINA, N., IDE, K. & KANAZAWA, I. (1997) Huntington’s disease gene product, huntingtin, associates with microtubules in vitro. Brain Research. Molecular Brain Research 51, 8–14.
  Article CAS PubMed Google Scholar
• USDIN, M. T., SHELBOURNE, P. F., MYERS, R. M. & MADISON, D. V. (1999) Impaired synaptic plasticity in mice carrying the Huntington’s disease mutation. Human Molecular Genetics 8, 839–846.
  Article CAS PubMed Google Scholar
• VELIER, J., KIM, M., SCHWARZ, C., KIM, T. W., SAPP, E., CHASE, K., ARONIN, N. & DIFIGLIA, M. (1998) Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Experimental Neurology 152, 34–40.
  Article CAS PubMed Google Scholar
• VONSATTEL, J. P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D. & RICHARDSON, E. P., JR. (1985) Neuropathological classification of Huntington’s disease. Journal of Neuropathology and Experimental Neurology 44, 559–577.
  CAS PubMed Google Scholar
• WANKER, E. E., ROVIRA, C., SCHERZINGER, E., HASENBANK, R., WALTER, S., TAIT, D., COLICELLI, J. & LEHRACH, H. (1997) HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system. Human Molecular Genetics 6, 487–495.
  Article CAS PubMed Google Scholar
• WOOLF, N. J. (1998) A structural basis for memory storage in mammals. Progress in Neurobiology 55, 59–77.
  Article CAS PubMed Google Scholar
• ZOGHBI, H. Y. & ORR, H. T. (2000) Glutamine repeats and neurodegeneration. Annual Review of Neuroscience 23, 217–247.
  Article CAS PubMed Google Scholar
• ZUCCATO, C., CIAMMOLA, A., RIGAMONTI, D., LEAVITT, B. R., GOFFREDO, D., CONTI, L., MACDONALD, M. E., FRIEDLANDER, R. M., SILANI, V., HAYDEN, M. R., TIMMUSK, T., SIPIONE, S. & CATTANEO, E. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 293, 493–498.
  Article CAS PubMed Google Scholar

Download references